Alar Pharmaceuticals Inc.

Taipei Exchange:6785.TWO

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

💊 Pharmaceuticals

Location

Taiwan

Market Cap

USD 321.56 M

Share Price

USD 4.81

Avg Daily Volume

154,950

Change (1 day)

0.41%

Change (1 year)

Change (YTD)

11.71%

Alar Pharmaceuticals Inc. Share Price Year-To-Date (YTD) return on June 20, 2025: 11.71%

Alar Pharmaceuticals Inc. Share Price Year-To-Date (YTD) return is 11.71% on June 20, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.

Alar Pharmaceuticals Inc. 52-week low Share Price is USD 7.05 on June 20, 2025, which is 46.51% above the current Share Price.
Alar Pharmaceuticals Inc. 52-week low Share Price is USD 3.43 on June 20, 2025, which is -28.65% below the current Share Price.
Alar Pharmaceuticals Inc. average Share Price for the last 52 weeks is USD 4.85.

Daily

From:

To:

Zoom:

Key data

Date	Share Price Year-To-Date (YTD) return	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)

Taipei Exchange: 6785.TWO

Alar Pharmaceuticals Inc.

CEO	Dr. Yung-Shun Wen Ph.D.
IPO Date	Oct. 5, 2020
Location	Taiwan
Headquarters	No. 32, Keya Road
Employees	27
Sector	🏥 Health Care
Industries Clinical Trials 💊 Pharmaceuticals

Description

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. It is developing ALA-1000, which is in Phase II clinical trials for the treatment of opioid use disorder; ALA-1300 and ALA-2000, which is in pre-clinical stage for opioid use disorder; ALA-4000 which is in pre-clinical stage for treatment of Parkinson's disease; and ALA-3000, which is in pre-clinical stage for treating treatment-resistant depression. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.